Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jun;24(6):512-523.
doi: 10.1016/S1474-4422(25)00154-1.

A new characterisation of acute traumatic brain injury: the NIH-NINDS TBI Classification and Nomenclature Initiative

Collaborators, Affiliations
Review

A new characterisation of acute traumatic brain injury: the NIH-NINDS TBI Classification and Nomenclature Initiative

Geoffrey T Manley et al. Lancet Neurol. 2025 Jun.

Abstract

The clinical severity of traumatic brain injury (TBI) is commonly classified according to the Glasgow Coma Scale (GCS) sum score as mild (13-15), moderate (9-12), or severe (3-8). A new approach is needed for characterising TBI more accurately. In 2022, the US National Institutes of Health-National Institute of Neurological Disorders and Stroke launched an international initiative to address this need, with a focus on the acute phase of injury. Six working groups of TBI experts, implementation scientists, people with lived experience, and federal partners were established, involving 94 participants from 14 countries. The proposed new framework for the characterisation of acute TBI incorporates four pillars: a clinical pillar (full GCS and pupillary reactivity); a biomarker pillar (blood-based measures); an imaging pillar (pathoanatomical measures); and a modifier pillar (features influencing clinical presentation and outcome; CBI-M). The CBI-M framework provides a multidimensional characterisation of TBI to inform individualised clinical management and to improve scientific rigor. Research priorities include validation of the CBI-M framework, evaluation of its applicability beyond the acute phase of TBI, and strategies for clinical implementation.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests GTM received research funding from NINDS, the US Department of Defense, Abbott Laboratories, the National Football League Scientific Advisory Board, and is a member of the NIH-NINDS steering committee initiative for improved characterisation and nomenclature of TBI. KD-O’C received research funding from the National Institute on Disability, Independent Living, and Rehabilitation Research and the US Department of Defense; consulting fees from Tampa VA Research Foundation; and travel support to attend meetings from National Neurotrauma Society. MA received research support from NIH and Life Molecular Imaging. JJB received consulting fees from Abbott Laboratories. PB and JC received travel support from NINDS. AF received research funding from NINDS, the US Department of Defense, the US Department of Veterans Affairs, Wings for Life Foundation, Craig H Neilsen Foundation, and Noyce Foundation. CLMD received research support from NIH and the US Department of Defense and travel support from NIH. DM received research funding from UK Research and Innovation, the National Institute for Health and Care Research, the Ministry of Defence (UK), and Alzheimer's Research UK and consulting fees from Neurotrauma Sciences, Lantmannen, GlaxoSmithKline, PressuraNeuro, CSL Behring, and Invex. MMM received research funding from the National Institute on Aging, the US Department of Defense, the Patient Centered Outcomes Research Institute, and Dexcom and royalites from Elsevier. JvdN received travel support from NIH. LDN received research support from NINDS and consulting fees from Resolys Bio. DP received research funding from the European Commission Seventh Framework Program, the Hannelore Kohl Stiftung, OneMind, Integra LifeSciences, and NeuroTrauma Sciences. NDS received research funding from NIH, Canadian Institutes of Health Research, Canada Foundation for Innovation, WorkSafeBC, Ontario Brain Institute, and the US Department of Defense. LW received consulting fees from Neurotrauma Sciences, Novartis, Mass General Brigham, and Medical College of Wisconsin, and travel support from NIH. ELY received research grants from NIH and the US Department of Defense. HZ received research funding from the Swedish Research Council, the EU's Horizon Europe Research and Innovation Programme, Swedish State Support for Clinical Research, Alzheimer Drug Discovery Foundation, and the EU Joint Programme. AIRM received research funding from the European Commission Seventh Framework Program and consulting fees from NeuroTrauma Sciences, GryphonBio, and PressuraNeuro. MAM received research funding from NINDS, the US Department of Defense, Abbott Laboratories, National Football League Scientific Advisory Board, National Collegiate Athletic Association, and is a member of the NIH-NINDS steering committee initiative for improved characterisation and nomenclature of TBI. All other authors declare no competing interests.

Comment in

MeSH terms

LinkOut - more resources